new glp-1 drug retatrutide Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide: A Promising Breakthrough for
Description
PMID 3543057
& Seino, Y
Atherosclerosis Up to 85% of cardiovascular deaths are related to atherosclerotic heart disease, which occurs as heart attacks and strokes
The added glucagon receptor activity is one reason researchers are studying whether retatrutide may produce different metabolic and weight-loss effects
[DOI] [PMC free article] [PubMed] [Google Scholar] 47.Zhou L, et al
Sources Latif W, Lambrinos KJ, Rodriguez R
